The results indicate that the high expression of FOXC1, FOXD1, FOXM1, and FOXL1 is associated with a shorter duration of both overall survival and disease-free survival in patients with PC (Fig. 1C and Supplementary Fig. S1). This evidence concerns the gene FOXL1 and pachyonychia congenita.